Correlation Between BrightGene Bio and Aurora Optoelectronics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BrightGene Bio and Aurora Optoelectronics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BrightGene Bio and Aurora Optoelectronics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BrightGene Bio Medical and Aurora Optoelectronics Co, you can compare the effects of market volatilities on BrightGene Bio and Aurora Optoelectronics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BrightGene Bio with a short position of Aurora Optoelectronics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BrightGene Bio and Aurora Optoelectronics.

Diversification Opportunities for BrightGene Bio and Aurora Optoelectronics

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between BrightGene and Aurora is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding BrightGene Bio Medical and Aurora Optoelectronics Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aurora Optoelectronics and BrightGene Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BrightGene Bio Medical are associated (or correlated) with Aurora Optoelectronics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aurora Optoelectronics has no effect on the direction of BrightGene Bio i.e., BrightGene Bio and Aurora Optoelectronics go up and down completely randomly.

Pair Corralation between BrightGene Bio and Aurora Optoelectronics

Assuming the 90 days trading horizon BrightGene Bio Medical is expected to generate 0.5 times more return on investment than Aurora Optoelectronics. However, BrightGene Bio Medical is 1.98 times less risky than Aurora Optoelectronics. It trades about -0.28 of its potential returns per unit of risk. Aurora Optoelectronics Co is currently generating about -0.34 per unit of risk. If you would invest  3,360  in BrightGene Bio Medical on October 17, 2024 and sell it today you would lose (405.00) from holding BrightGene Bio Medical or give up 12.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BrightGene Bio Medical  vs.  Aurora Optoelectronics Co

 Performance 
       Timeline  
BrightGene Bio Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BrightGene Bio Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BrightGene Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Aurora Optoelectronics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aurora Optoelectronics Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Aurora Optoelectronics sustained solid returns over the last few months and may actually be approaching a breakup point.

BrightGene Bio and Aurora Optoelectronics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BrightGene Bio and Aurora Optoelectronics

The main advantage of trading using opposite BrightGene Bio and Aurora Optoelectronics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BrightGene Bio position performs unexpectedly, Aurora Optoelectronics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aurora Optoelectronics will offset losses from the drop in Aurora Optoelectronics' long position.
The idea behind BrightGene Bio Medical and Aurora Optoelectronics Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum